Cellectis: FDA Approves IND Application for UCART20x22
ADC评论
August 5, 2022
On August 1, Universal CAR-T (UCAR-T) pioneer Cellectis announced that the U.S. FDA has approved the company’s IND application for UCART20x22 to initiate this product
